Cargando…

Convergent QSAR Models for the Prediction of Cruzain Inhibitors

[Image: see text] Chagas disease is a parasitosis caused by Trypanosoma cruzi. Cruzain, the major cysteine protease from T. cruzi, is an excellent therapeutic target in the search for antichagasic drugs. It is important in the role of cell invasion, replication, differentiation, and metabolism of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves, Rafael Bello, Ferraz, Witor Ribeiro, Calil, Raisa Ludmila, Scotti, Marcus Tullius, Trossini, Gustavo Henrique Goulart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601054/ https://www.ncbi.nlm.nih.gov/pubmed/37901514 http://dx.doi.org/10.1021/acsomega.3c03376

Ejemplares similares

Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study
por: Ferraz, Witor Ribeiro, et al.
Publicado: (2020)

Novel Cruzain Inhibitors for the Treatment of Chagas’ Disease
por: Rogers, Kathleen E, et al.
Publicado: (2012)

Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage
por: Rosas-Jimenez, Jose Guadalupe, et al.
Publicado: (2021)

Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors
por: Medeiros, Alex R., et al.
Publicado: (2021)

Computational approaches towards the discovery and optimisation of cruzain inhibitors
por: Santos, Viviane Corrêa, et al.
Publicado: (2022)

Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors
por: Avelar, Leandro A. A., et al.
Publicado: (2015)

Hologram QSAR Studies of Antiprotozoal Activities of Sesquiterpene Lactones
por: Trossini, Gustavo H. G., et al.
Publicado: (2014)

Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics
por: Pauli, Ivani, et al.
Publicado: (2022)

Computational Identification of Uncharacterized Cruzain Binding Sites
por: Durrant, Jacob D., et al.
Publicado: (2010)

The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
por: Doyle, Patricia S., et al.
Publicado: (2011)

Non-peptidic Cruzain Inhibitors with Trypanocidal Activity Discovered by Virtual Screening and In Vitro Assay
por: Wiggers, Helton J., et al.
Publicado: (2013)

Structure-Based Virtual Screening and In Vitro Evaluation of New Trypanosoma cruzi Cruzain Inhibitors
por: Herrera-Mayorga, Verónica, et al.
Publicado: (2019)

Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors
por: do Valle Moreira, Thales, et al.
Publicado: (2023)

Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors
por: Ferreira, Rafaela S., et al.
Publicado: (2010)

QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites
por: Kleandrova, Valeria V., et al.
Publicado: (2021)

Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
por: Choy, Jonathan W, et al.
Publicado: (2013)

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
por: Palos, Isidro, et al.
Publicado: (2017)

Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-Trypanosoma cruzi Activity
por: Ferreira, Rafael A. A., et al.
Publicado: (2019)

Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach
por: Hernández Alvarez, Lilian, et al.
Publicado: (2019)

Combining Charge Density Analysis with Machine Learning Tools To Investigate the Cruzain Inhibition Mechanism
por: Luchi, Adriano M., et al.
Publicado: (2019)

Chemometric Studies on Natural Products as Potential Inhibitors of the NADH Oxidase from Trypanosoma cruzi Using the VolSurf Approach
por: Scotti, Luciana, et al.
Publicado: (2010)

QSAR analysis on tacrine-related acetylcholinesterase inhibitors
por: Wong, Kai Y, et al.
Publicado: (2014)

Impact of the Recognition Part of Dipeptidyl Nitroalkene Compounds on the Inhibition Mechanism of Cysteine Proteases Cruzain and Cathepsin L
por: Arafet, Kemel, et al.
Publicado: (2023)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I
por: Herrera-Acevedo, Chonny, et al.
Publicado: (2021)

Kaurane-Type Diterpenoids as Potential Inhibitors of Dihydrofolate Reductase-Thymidylate Synthase in New World Leishmania Species
por: Herrera-Acevedo, Chonny, et al.
Publicado: (2023)

Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2019)

Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2023)

QSAR Studies on Andrographolide Derivatives as α-Glucosidase Inhibitors
por: Xu, Jun, et al.
Publicado: (2010)

QSAR Accelerated Discovery of Potent Ice Recrystallization Inhibitors
por: Briard, Jennie G., et al.
Publicado: (2016)

QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
por: Santos-Garcia, Letícia, et al.
Publicado: (2018)

Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
por: Gheidari, Davood, et al.
Publicado: (2021)

Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
por: Rodrigues-Junior, Dorival Mendes, et al.
Publicado: (2022)

Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases 2020
por: Mendonça-Junior, Francisco Jaime Bezerra, et al.
Publicado: (2021)

QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
por: Ponzoni, Ignacio, et al.
Publicado: (2019)

Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity
por: de Menezes, Renata Priscila Barros, et al.
Publicado: (2022)

3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis
por: Bhattacharjee, Atanu, et al.
Publicado: (2012)

QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease
por: Sebastián-Pérez, Víctor, et al.
Publicado: (2019)

QSAR workbench: automating QSAR modeling to drive compound design
por: Cox, Richard, et al.
Publicado: (2013)

Diosgenone Synthesis, Anti-Malarial Activity and QSAR of Analogues of This Natural Product
por: Pabón, Adriana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1sr1n075etojoq6uneuu83jnks